论文部分内容阅读
作者对204例各种肝脏疾病患者,进行了酚四溴酜鈉BSP試驗的研究,并以其他的肝脏功能試驗作对照,許多患者的診断,是借腹窺鏡檢查予以証实的。按照公斤体重靜脉注射BSP 5毫克,30与60分钟后采血测定血中瀦留的濃度,正常注射后30分鏡血中的濃度,为注入量的10％.60分鐘为3％,超过这种数值則認为本試驗阳性,表示肝脏功能有損害現象。(一)75例急性傳染性肝炎73例阳性,証明其敏感性超过其他肝功能試驗,对病情与預后的估价,本試驗也有极重要的指示,30分鐘瀦留濃度超过60％吋,表示肝腸实質有严重的損害,其病程經过亦较严重,所見的
The authors studied 204 patients with various liver diseases, phenobarbital sodium BSP test and other liver function tests as a control, many patients diagnosed by endoscopy to be confirmed. According to the body weight of intravenous injection of BSP 5 mg, 30 and 60 minutes after the determination of blood concentration of blood retention, 30 minutes after normal injection of blood concentration, injection of 10%. 60 minutes to 3%, more than this value The test is positive, indicating that liver function damage. (A) of 75 cases of acute infectious hepatitis, 73 cases were positive, proving its sensitivity over other liver function tests, the assessment of the disease and prognosis, this test is also very important instructions, 30 minutes retention concentration of more than 60% inch, said the intestine Seriously serious damage, the course of the disease is also more serious, seen